PHILIBERT ROBERT has a total of 22 patent applications. Its first patent ever was published in 1904. It filed its patents most often in United States, Australia and Canada. Its main competitors in its focus markets biotechnology, measurement and machines are EXACT LAB INC, BEIJING YIXIN BOCHUANG BIOLOGICAL TECHNOLOGY CO LTD and CHRONIX BIOMEDICAL.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | Australia | 2 | |
#3 | Canada | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Singapore | 2 | |
#6 | WIPO (World Intellectual Property Organization) | 2 | |
#7 | China | 1 | |
#8 | France | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Norway | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement | |
#3 | Machines | |
#4 | Transport |
# | Technology | |
---|---|---|
#1 | Measuring microorganism processes | |
#2 | Analysing materials | |
#3 | Unspecified technologies | |
#4 | Power supply for electric vehicles |
# | Name | Total Patents |
---|---|---|
#1 | Philibert Robert | 21 |
#2 | Madan Anup | 6 |
#3 | Todorov Alexandre | 4 |
#4 | Todorow Alexandre | 1 |
#5 | Robert Philibert | 1 |
Publication | Filing date | Title |
---|---|---|
KR20170013921A | Dna methylation status as a biomarker of alcohol use and abstinence | |
US2017183728A1 | Methods and compositions for predicting tobacco use | |
US2007292880A1 | Compositions and methods for detecting predisposition to a substance use disorder or to a mental illness or syndrome | |
US2007248576A1 | Regulation of the serotonin reuptake transporter and disease |